Ibrahim Kulac

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Diagnostic cytopathology

Molecular cancer research : MCR

PloS one

Cancer prevention research (Philadelphia, Pa.)

Koç Üniversitesi Tıp Fakültesi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Koç Üniversitesi Tıp Fakültesi

Turkey

Assistant Professor :: Pathology

Johns Hopkins University School of Medicine

United States

Postdoctoral Research Fellow :: Pathology

Publications

Çişel Meriçöz, Ozgur Can Eren, Ibrahim Kulac, Pinar Firat
Fusion of old and new: Employing touch imprint slides for next generation sequencing in solid tumors. Diagnostic cytopathology (2024)
Çişel Meriçöz, Ozgur Can Eren, Ibrahim Kulac, Pinar Firat
Fusion of old and new: Employing touch imprint slides for next generation sequencing in solid tumors. Diagnostic cytopathology 52 (5) (2024)
Çişel Meriçöz, Ozgur Can Eren, Ibrahim Kulac, Pinar Firat
Fusion of old and new: Employing touch imprint slides for next generation sequencing in solid tumors. Diagnostic cytopathology 52 (5) (2024)
Ozgur Can Eren, Cisel Aydin Mericoz, Emine Bozkurtlar, Pinar Bulutay, Arzu Baygul, Ibrahim Kulac
Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas : A validation study. American journal of clinical pathology (2023)
Igor Vidal, Qizhi Zheng, Jessica L Hicks, Jiayu Chen, Elizabeth A Platz, Bruce J Trock, Ibrahim Kulac, Javier A Baena-Del Valle, Karen S Sfanos, Sarah E Ernst, Tracy Jones, Janielle P Maynard, Stephanie A Glavaris, William G Nelson, Srinivasan Yegnasubramanian, Angelo M DeMarzo
GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States. PloS one 16 (6) (2021)
Heidi Hempel Sullivan, Christopher M Heaphy, Ibrahim Kulac, Nathan Cuka, Jiayun Lu, John R Barber, Angelo M DeMarzo, Tamara L Lotan, Corrine E Joshu, Karen S Sfanos
High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (3) (2020)
Lauren M Hurwitz, Ibrahim Kulac, Berrak Gumuskaya, Javier A Baena Del Valle, Ines Benedetti, Fan Pan, Jun O Liu, Michael T Marrone, Kathryn B Arnold, Phyllis J Goodman, Catherine M Tangen, M Scott Lucia, Ian M Thompson, Charles G Drake, William B Isaacs, William G Nelson, Angelo M DeMarzo, Elizabeth A Platz
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer prevention research (Philadelphia, Pa.) 13 (10) (2020)
Janielle P Maynard, Onur Ertunc, Ibrahim Kulac, Javier A Baena-Del Valle, Angelo M DeMarzo, Karen S Sfanos
IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer. Molecular cancer research : MCR 18 (1) (2019)

Ibrahim Kulac.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ibrahim Kulac